Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study

OBJECTIVES: This analysis from the PERSPECTIVE (a Prospective, Non‐interventional Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder) study evaluated treatment persistence with mirabegron or antimuscarinics over a 12‐month period. METHODS: Participants were adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Kevin V., Rovner, Eric S., Nair, Kavita V., Deal, Anna S., Kristy, Rita M., Hairston, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Asia Pty Ltd 2021
Materias:
Original Articles ‐ Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518921/
https://www.ncbi.nlm.nih.gov/pubmed/33987973
http://dx.doi.org/10.1111/luts.12382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518921/
https://www.ncbi.nlm.nih.gov/pubmed/33987973
http://dx.doi.org/10.1111/luts.12382

Ejemplares similares